Evidence map›Paper›PMID 12587072›Full record

ArticleJournal of neurovirology2003

Elevated peripheral benzodiazepine receptor expression in simian immunodeficiency virus encephalitis.

Joseph L Mankowski, Suzanne E Queen, Patrick J Tarwater, Robert J Adams, Tomas R Guilarte

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurovirology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Microglia and inflammation in Alzheimer's disease.CNS & neurological disorders drug targets · 2010
    Review
  11. Imaging microglial activation during neuroinflammation and Alzheimer's disease.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2009
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Joseph L MankowskiDepartment of Comparative Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA. jmankows@jhmi.edu
Suzanne E Queen
Patrick J Tarwater
Robert J Adams
Tomas R Guilarte
Johns Hopkins University · US

Funding

CHEMOKINES AND CHEMOKINE RECEPTORS IN SIV ENCEPHALITISR01MH061189 · NIMH · JOHNS HOPKINS UNIVERSITY · PI ZINK, M CHRISTINE · 1999 to 2003
$2.0M
VIRUS AND HOST FACTORS IN SIV ENCEPHALITISR01NS036911 · NINDS · JOHNS HOPKINS UNIVERSITY · PI ZINK, M CHRISTINE · 1997 to 2000
$299k
BLOOD BRAIN BARRIER AND SIV ENCEPHALITISK01RR000116 · NCRR · JOHNS HOPKINS UNIVERSITY · PI MANKOWSKI, JOSEPH L · 1996 to 2000
$125k
NCRR NIH HHS RR00116NIEHS NIH HHS ES07062NIMH NIH HHS MH61189NINDS NIH HHS NS36911
6 · The paper itself

Abstract

Measurement of central nervous system (CNS) expression of the peripheral benzodiazepine receptor (PBR), a microglia and macrophage activation marker, by positron emission tomography (PET) would aid clinical management of human immunodeficiency virus (HIV)-infected patients. To evaluate the utility of examining PBR expression in the CNS as a cellular activation marker in HIV CNS disease, PBR levels were measured in frontal cortex of simian immunodeficiency virus (SIV)-infected macaques with encephalitis and uninfected animals via PK11195 ligand autoradiography. [(3)H]-(R)-PK11195 binding to both grey matter (P =.017) and white matter (P =.038) was significantly higher in animals with SIV encephalitis (n = 10) versus control animals (n = 3). When PK11195 binding was compared with other microglial/macrophage activation markers (obtained via quantitative image analysis), a strong, significant association was found for both HAM56 (P =.004) and KP-1 (anti-CD68; P =.006) immunostaining in white matter. In contrast, grey matter PK11195 binding did not correlate with HAM56 (P =.46), KP-1 (P =.06), or glial fibrillary acidic protein (GFAP) immunostaining for astrocytic activation (P =.09). The regional nature of these increases in activation within the brain illustrates the crucial need to focus functional neuroimaging analyses of HIV-infected individuals on subcortical white matter to assess activation of microglia and macrophages.

Indexed as

Simian Immunodeficiency VirusAnimalsAntineoplastic AgentsEncephalitis, ViralGliosisIsoquinolinesMacaca nemestrinaMacrophagesMicrogliaReceptors, GABA-ASimian Acquired Immunodeficiency SyndromeAntineoplastic AgentsIsoquinolinesPK 11195Receptors, GABA-A

Identifiers

PMID12587072
OpenAlexW1965102491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.